Results 141 to 150 of about 4,498 (153)
Some of the next articles are maybe not open access.

Targeting CCL24 in primary sclerosing cholangitis with CM101: rationale and study design

Journal of Hepatology, 2023
Douglas Thorburn   +9 more
openaire   +1 more source

Abstract B018: CCL24+ monocytes drives resistance to anti-PD-L1 blockade in hepatocellular carcinoma

Cancer Immunology Research
Abstract Background: Immunotherapy has promising anti-tumor activity in patients with advanced Hepatocellular carcinoma (HCC). However, the objective response rate of PD-L1 blockade is limited. Therefore, there is an urgent need to explore resistance mechanisms in immunotherapy.
HAIJING DENG   +9 more
openaire   +1 more source

Eotaxins (CCL11, CCL24, CCL26)

2016
Timothy John Williams   +1 more
openaire   +1 more source

POS1257 CCL24 SERUM CONCENTRATION PREDICTS BOTH VASCULAR AND FIBROTIC COMPLICATIONS IN SYSTEMIC SCLEROSIS

Annals of the Rheumatic Diseases, 2023
E. De Lorenzis   +7 more
openaire   +1 more source

Eosinophils and eosinophil chemokines, CCL11, CCL24 and CCL26, in refractory pediatric Crohnʼs Disease

Inflammatory Bowel Diseases, 2007
Hogan Simon   +5 more
openaire   +1 more source

A novel CCL24 blocking monoclonal antibody ameliorates liver injury in experimental models of cholestasis

Journal of Hepatology, 2018
M. Segal   +7 more
openaire   +1 more source

Home - About - Disclaimer - Privacy